pharma · Refractory Partial Onset Epilepsy · Multiple Sclerosis
NEURAXPHARM AUSTRALIA PTY
NEURAXPHARM AUSTRALIA PTY LIMITED
NEURAXPHARM AUSTRALIA PTY clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Melbourne, AU HQ
11 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Employees
- 11
- Programs
- 3
- Drugs
- 17
- Patents
- 0
NEURAXPHARM AUSTRALIA PTY projects
3 ClinicalTrials.gov programs sponsored by NEURAXPHARM AUSTRALIA PTY.
NEURAXPHARM AUSTRALIA PTY has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does NEURAXPHARM AUSTRALIA PTY have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.